Jump Financial’s Iterum Therapeutics ITRM Stock Holding History

Jump Financial’s Portfolio ITRM Stock Details ITRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-72,156	Closed	-$2.17K	–	2244
2026 Q1	$2.17K	Buy	+72,156	New	+$18.1K	﹤0.01%	1816

Other funds holding ITRM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Jump Financial's ITRM Position: Q2 2026 in Review

Jump Financial sold out of Iterum Therapeutics (ITRM) in Q2 2026, closing a stake of 72,156 shares — an estimated $2.17K sold.

Jump Financial first reported a position in ITRM in Q1 2026 and held it in 1 quarter. The position peaked at $2.17K in Q1 2026. 2 funds tracked by Wall St. Rank hold ITRM as of Q2 2026.

Jump Financial reported no remaining Iterum Therapeutics position as of Q2 2026 after selling out during the quarter.
Jump Financial sold 72,156 Iterum Therapeutics shares in Q2 2026, an estimated $2.17K.
Jump Financial first reported a position in Iterum Therapeutics in Q1 2026 and held it in 1 quarter.
Jump Financial's Iterum Therapeutics position peaked at $2.17K in Q1 2026.
2 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.